Use of heated tobacco products, moderate alcohol drinking, and anti-SARS-CoV-2 IgG antibody titers after BNT162b2 vaccination among Japanese healthcare workers

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

No abstract available

Article activity feed

  1. SciScore for 10.1101/2021.11.29.21267032: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    EthicsConsent: Written informed consent was obtained from each participant.
    IRB: The study design and procedure for data collection were approved by the ethical committee of each center, while those of pooling study were approved by that of the National Center for Global Health and Medicine (NCGM) (the approved number: NCGM-G-004233).
    Sex as a biological variablenot detected.
    Randomizationnot detected.
    Blindingnot detected.
    Power AnalysisIn post hoc analysis, we combined the categories of exclusive HNB tobacco users and dual users in one to increase statistical power.

    Table 2: Resources

    Antibodies
    SentencesResources
    Serological assay: We quantitatively measured SARS-CoV-2 IgG antibodies against spike protein in serum using the chemiluminescence enzyme immunoassay (CLEIA) platform (HISCL) manufactured by Sysmex Co. (Kobe, Japan).
    SARS-CoV-2 IgG
    suggested: None
    Statistical analysis: We performed multilevel linear regression analysis to examine the associations of smoking and alcohol use with anti-spike IgG antibody titers in log-scale.
    anti-spike IgG
    suggested: None
    We drew a restricted cubic spline curve to visualize the dose-response association between alcohol consumption and IgG antibody titers, with 3 knots placed at the 5th, 50th, and 95th percentiles as recommended.
    IgG
    suggested: None
    Software and Algorithms
    SentencesResources
    The sensitivity and specificity were reported as 98.3% and 99.6%, respectively.12 We confirmed that IgG antibody titers measured on this assay were highly correlated with those measured on the AdviseDx SARS-CoV-2 IgG II assay (Abbott ARCHITECT®) using data of two centers that measured antibodies with both assays (n=2,961): spearman’s rho = 0.96 (95% confidence intervals [CI]: 0.95–0.96)
    Abbott
    suggested: (Abbott, RRID:SCR_010477)
    14 Statistical analysis was performed using Stata 17.0 (StataCorp LLC).
    StataCorp
    suggested: (Stata, RRID:SCR_012763)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    We should also acknowledge study limitations. First, as this study is cross-sectional, we cannot determine whether smoking and alcohol use were associated with the surge of antibodies in response to vaccination or the decay of antibodies over time. Second, the number of exclusive HNB tobacco users was not large enough to detect the reduction of IgG titers among them with statistical significance. Third, we did not measure neutralizing antibody, a more reliable marker of immunogenicity. Nevertheless, spike IgG antibody titers measured with the assay we employed are known to well correlate with neutralizing antibody titers (spearman’s ρ=0.71, 95% CI: 0.63–0.77).19 Finally, many East Asians are genetically deficient in one of the enzymes involved in metabolizing alcohol (aldehyde dehydrogenase);11 thus, the present finding regarding alcohol use may not be observed in populations with different genetic background. In conclusion, cigarettes smokers and, to a lesser extent, HNB tobacco product users had lower IgG antibody titers against SAR-CoV-2 spike protein after vaccination, relative to never-smokers. The antibody titers steadily decreased with increasing alcohol consumption, with significant reduction being observed even at moderate amount of alcohol. In addition to conventional cigarette smoking and heavy alcohol use, the use of HNB tobacco products and moderate alcohol drinking may deteriorate immune response to COVID-19 vaccine.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a protocol registration statement.

    Results from scite Reference Check: We found no unreliable references.


    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.